Clinical trial
Assessing the Effectiveness of Juniper and Thyme Essential Oils in Mitigating Physiological Symptoms of Examination-Induced Anxiety in Medical Students
NCT07922278 is registered in ClinicalTrials.gov with Gulbahar Boyuk Ozcan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Effectiveness of Juniper and Thyme Essential Oils in Mitigating Physiological Symptoms of Examination-Induced Anxiety in Medical Students
- Lead sponsor
- Gulbahar Boyuk Ozcan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 7, 2024
- Completion date
- October 10, 2024
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
examination anxiety, psychological stress, situational anxiety, test anxiety
Arms
As registered; 2 arms.
-
Arm 1: Juniper Aromatherapy Group
Participants inhale juniper essential oil for 15 minutes prior to the exam. Physiological and hormonal measurements are taken immediately before and after the inhalation.
-
Arm 2: Thyme Aromatherapy Group
Participants inhale thyme essential oil for 15 minutes prior to the exam. Physiological and hormonal measurements are taken immediately before and after the inhalation.
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Change in Salivary Cortisol Levels
Saliva samples will be collected immediately before and 15 minutes after aroma inhalation to measure cortisol levels using the ELISA method.
-
Change in Salivary Asprosin Levels
Saliva samples will be analyzed using the ELISA method to measure asprosin levels, serving as a physiological stress indicator.
-
Change in Salivary CREB Levels
Salivary CREB concentrations will be measured using the ELISA method to evaluate biochemical stress responses.
Lead sponsor's other trials
Gulbahar Boyuk Ozcan, most recent start first.
Similar trials
Same condition (Arachnodactyly) and phase, most recent start first.
+5 more trials See the condition page